Editors' Pick MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary. Hutchinson M Mult Scler. 2014 Mar; 20(3):284-5. Epub 1969 Dec 31. PMID: 24589687. Abstract CommentRecommendBookmarkWatch